Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02104882 : INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
PhasePhase 1/Phase 2
AgesMin: 50 Years Max: N/A
Eligibility
Inclusion Criteria:

- Histologically confirmed glioblastoma multiforme in frozen sections

- Age ?50 years

- Karnofsky Performance Index ? 50%

- Informed consent

- Adequate birth control (e.g., oral contraceptives)

Exclusion Criteria:

- Astrocytoma ? WHO grade III

- Gliomatosis cerebri

- Multifocal lesions

- Infratentorial localization

- Previous cranial radiation therapy (any location)

- Uncontrolled intercurrent illnesses including, but not limited to, ongoing or active
infection or psychiatric illness/social situations that would limit compliance with
study requirements.

- Contraindications for general anaesthesia

- Bleeding or clotting disorders

- Contraindications for MRI or CT scans

- Pregnant or breastfeeding women
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02104882      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740